“Hunger Hormone” No More?

Ghrelin promotes fat storage not feeding, according to a study.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PHILIPPE ZIZZARITransgenic mice with an overactive form of the receptor for ghrelin—often dubbed the “hunger hormone”—do not have the increased appetites one might expect, yet still gain weight, according to a paper published yesterday (April 19) in Science Signaling. The results suggest that the long-held view of ghrelin as a regulator of food intake may not be entirely accurate. But not everyone is convinced.

“It’s an intellectually intriguing finding,” said Yale School of Medicine’s Tamas Horvath who was not involved in the study. “Am I 100 percent convinced that this proves that ghrelin has no effect on feeding? No. But I think that [the authors] come up with a provocative set of data and I think . . . it’s going to initiate more thorough studies on this important question,” he added.

Ghrelin and its only known receptor, the growth hormone secretagogue receptor (GHSR), have been implicated in, among other things, food intake, growth hormone secretion, and the production of fatty tissue (adipogenesis). Injections of ghrelin, for example, have been shown to increase food intake and adipogenesis in rodents. In humans, levels of ghrelin in the blood have been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies